Do you want to shape the future of longevity science? VitaDAO's new Fellowship Program offers a unique opportunity for you to break free from rigid academic structures and push the frontier of longevity science!

Introducing VitaLabs Imagine a world where death is optional. Today, we take a bold step towards that future with the launch of VitaLabs, VitaDAO's in-house network of interdisciplinary scientists dedicated to radically extending human healthspan.

Welcome back Vitalians, it’s been an eventful month in longevity and DeSci. Please join us in congratulating the TransFidelity team for passing the VitaDAO token holder vote. This proposal will allocate $50,000 to TransFidelity, a project focused on

In this episode of the Aging Science Podcast by VitaDAO, we explore the connection between environmental pollution and longevity with Dr. Dushani Palliyaguru. Delve into the Nrf2 pathway, a critical mechanism for cellular defense, and...

Welcome back, Vitalians! This month we’re celebrating VitaDAO’s 3rd birthday! It’s been an exciting journey, and we’re thrilled to share our progress and future plans with you. In the past three years, VitaDAO has evaluated over 200 projects, funded

In this episode of The VitaDAO Aging Science Podcast, we uncover the secretive yet pivotal rapamycin study led by Prof. Adam Salmon. Prof. Salmon, a prominent figure in aging research, shares his insights

Welcome back, Vitalians! Please join us in congratulating the ARTAN team for raising $300k in VitaDAO’s 2nd IPT launch! We look forward to bringing you more updates on this exciting project as the team works towards developing therapeutic candidates

Tokenizing the Artan Bio IP-NFT

Welcome back Vitalians and please join us in congratulating The Fission Pharma team for passing the Snapshot vote to receive VitaDAO funding!

Hi Vitalians, greetings from Vitalia. You might have heard about the city of life in Roatan, Honduras. 

We're introducing a revolutionary feature soon for $VITA token holders: the ability to stake $VITA your tokens in exchange for premier health products and services aimed at enhancing your longevity.

The curious technophile ventures forth across the small and wondrous meatspace of a pop-up city-within-a-charter-city in Roatan, Honduras, chronicling the emergence of an experimental biotech startup hub, crypto-augmented Special Economic Zone

Welcome back Vitalians. I’m sure that most of you would have by now heard the sad news that renowned Professor Judith Campisi has passed away. In place of our usual interview, this month ...

What an extraordinary year it has been! Since June 23rd, 2021, the day VitaDAO's Gnosis Auction funded our Treasury, VitaDAO has been funding longevity research and fostering a community of passionate researchers, enthusiasts & professionals.

Welcome to 2024, Vitalians! We hope your holiday season was wonderful, and that you're returning recharged and ready for another year of exciting developments in longevity science!

In the upcoming episode of The Science of Aging Podcast, we're set to explore aging research with Dr. Jesse Poganik and Dr. Mahdi Moqri, just before the 2023 Biomarkers of Aging Symposium. Dr. Poganik ...

Welcome back Vitalians and please join us in congratulating the Remedium Bio team for passing the VitaDAO token holder vote with 75.61% voting in favour!

This special the episode of the Aging Science podcast is brought to you from the ARDD conference that took place at the end of August in Kopenhagen. I sat together with Dr. David Meyer from CECAD and Prof. Sarah Voisin ...

Welcome back Vitalians and please join us in congratulating the Oisín Biotechnologies team for passing the VitaDAO token holder vote with 86.47% voting in favour! This proposal was an assessment of a multi-asset longevity biotech...

VitaDAO is partnering with leading companies to offer substantial discounts on their products and services, exclusively for our members.

In the intricate ballet of cellular activity, mitochondria often play a leading role. These double-membraned organelles are frequently referred to as the "powerhouses" of the cell, converting nutrients into energy that...

Welcome back Vitalians, it’s a big week for VitaDAO as we’ve just become the first DAO to kickstart a biotech company, MatrixBio. MatrixBio explores hyaluronic acid-based compounds, aiming to pioneer in cancer and aging treatments...

Imagine a bustling factory, working tirelessly day and night, crafting intricate items with utmost precision. This isn't a scene from a high-tech industrial park; it's happening right now inside your body.

Welcome back Vitalians and please join us in congratulating the Cyclarity Therapeutics (CTx) team for passing the VitaDAO token holder vote! This proposal was an assessment of an early-stage biotechnology company...

In this episode of The VitaDAO Aging Science Podcast, we delve into the world of age-related eye diseases with Prof. Dorota Skowronska-Krawczyk, a renowned expert in vision and aging. We explore fundamental aging mechanisms, challenges in research...

Scientists are forever searching for ways to rejuvenate aged cells and organisms back to a more youthful and healthier state - from stem cell therapies to telomere lengthening, or even the Frankenstein-esque heterochronic parabiosis experiments...

In the 7th episode of the Aging Science podcast we talked with Prof. Vera Gorbunova about her most recent work, covering a wide array of topics from genome stability, naked mole rats, the role of hyaluronan in cancer prevention..

Welcome back Vitalians! Stop the press - the Impetus Longevity grants are back!

We talked with Prof. Joao Pedro De Magalhaes about about cryonics, transhumanism, the need for a “Sputnik moment” in longevity research, fish oil and rilmenidine for longevity, inflammaging, and cellular reprogramming.

Welcome to this month's newsletter, where we delve into the philosophical dichotomy at the heart of longevity research.

In this podcast with Dr. Heidi Pak we primarily talked about the difference between fasting and time-restricted feeding, how and why it works and also the efficacy of caloric restriction (CR) in different mouse strains and species.

Introduction Welcome to this month's edition of our newsletter, where we delve into the fascinating realm of gerontology - the scientific study of ageing - which has increasingly become a pivotal area of research, given the world's ageing population.

In this episode of the Aging Science podcast we talked with Prof. Nir Eynon (@nir_eynon). We touched on many topics, including elite athletes, how COVID affected working culture (for the better), the benefits of tabatas, epigenetic and muscle clocks

We are thrilled to celebrate our one-year anniversary of bringing you the latest research, insights, and developments in our field. Over the past year, we have covered a wide range of topics, from artificial intelligence and sustainability to genetic

I (@aging_scientist) had a marvelous conversation with Assoc. Prof. Viktor Korolchuk (@VIKorolchuk) about autophagy, mitochondria, senescence, the importance of modelling, and human desire for radical lifespan extension.

Welcome back Vitalians! In recent years, autophagy has emerged as an important topic in the field of aging biology and is now considered a major Hallmark of Aging.

In this podcast, I (@aging_scientist) spoke with Dr. Rich Miller about the ins and outs of mouse aging.

Following our successful fundraise of $4.1 million (check out the Forbes article), a new wave of projects are in the pipeline to be funded. First up in 2023 is Brain Tissue Replacement Therapy with Jean Hebert

The Longevity field is starting the year strongly with new updated Hallmarks of aging, exactly 10 years after the original paper was published. So time to update your introduction slides with the figure we will see in every presentation for the next

2023 kicks off with strong support for longevity research and a huge step for decentralized science(DeSci)

As the end of the year is fast approaching we wanted to look back and appreciate all the effort and hard work of the researchers in the VitaDAO community - from students, postdocs and fellows to principal investigators

Therapies that act synergistically are needed to significantly promote longevity

A multitude of discoveries and inventions throughout history have been made by people who were initially trained in one domain, but were able to make a significant contribution to a different field due to their ability to look at a problem with a uni

Inside: A Recap of VitaDAO’s 2nd “Crypto meets Longevity Symposium” VitaDAO Fellowship Update New VitaSpotlight Series: Rapamycin as a Promising Aging Intervention How to contribute to VitaDAO and ResearchHub’s Community Driven Paper Meet DAO Membe

It was in 1975 when scientists from Ayerst (now Pfizer) discovered a novel compound called rapamycin (also known as Sirolimus) in bacteria on Rapa Nui(Easter Island) in Chile. In 1999 rapamycin obtained FDA approval for the prevention of acute reject

Some species in the animal kingdom live extraordinarily long lives. They seem to be somehow protected from all the damage that we would expect to accumulate in aged tissues. Many are very large, like bowhead whales, and there is an established correl

Welcome back to our monthly newsletter! This month we are excited to bring you an interview with Dr. Marco Demaria who has made some significant contributions to our understanding of cellular senescence. 

We can all agree that the age-associated decline in physiological functionality and increased risk of developing diseases is terrible, but what can we do to treat, slow down or even prevent it?

We are announcing The Longevity Prize in collaboration with Foresight.‍ A series of prizes to honor and accelerate progress in longevity and rejuvenation. ‍The longevity prize encourages novel approaches for turning back our aging clocks.

Why do we age? Is aging a result of a genetic program encoded within each of our cells, or is it simply a consequence of damage accumulation throughout life?

Welcome back to VitaDAO’s monthly longevity research newsletter — we hope you enjoyed our maiden issue!

Welcome Vitalians to the inaugural issue of VitaDAO’s Monthly Longevity Research Newsletter!

Humans can instinctively recognize if someone appears older or younger than their age; so then, it should be apparent that many species, including humans, develop age-related changes at different rates.

Originally described as gradual deterioration over time, senescence has taken on a much more intricate meaning in the past few decades.

We are getting quite good at extending lifespan, or at least we are getting quite good at extending the lifespan of laboratory animals as complex as mice.

We’re excited to introduce the opening project to be funded by VitaDAO — the world’s first decentralized intellectual property collective.

Welcome back Vitalians!VitaDAO is excited to announce the launch of VitaLabs - our new Venture Studio, comprising an in-house network of interdisciplinary scientists dedicated to generating novel IP with a view to extending human healthspan.